Brief: Catalent Q4 Revenue USD 1,300 Million Vs. IBES Estimate USD 1,224 Million
29/08/2024 12:30
Aug 29 (Reuters) - Catalent Q4 adjusted net income USD 118 million vs. IBES estimate USD 84.8 million. * Q4 adjusted EBITDA USD 305 million vs. IBES estimate USD 259.4 million
Recent news on Catalent
See all newsBrief: Novo Holdings Completes Acquisition Of Catalent
Novo Nordisk rises as Catalent deal in US nears
Regulatory conditions on Novo Holdings' $16.5 bln Catalent deal fulfilled, companies say
Brief: Catalent And Novo Holdings Fulfill All Regulatory Closing Conditions For Pending Transaction
Brief: Novo Nordisk Says All Regulatory Closing Conditions Relating To Review Of Novo Holdings A/S's Pending Acquisition Of Catalent Have Been Fulfilled